These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 24204634)

  • 41. Comparative Evaluation of the Antimicrobial Activity of Different Antimicrobial Peptides against a Range of Pathogenic Bacteria.
    Ebbensgaard A; Mordhorst H; Overgaard MT; Nielsen CG; Aarestrup FM; Hansen EB
    PLoS One; 2015; 10(12):e0144611. PubMed ID: 26656394
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The antimicrobial peptide-sensing system aps of Staphylococcus aureus.
    Li M; Cha DJ; Lai Y; Villaruz AE; Sturdevant DE; Otto M
    Mol Microbiol; 2007 Dec; 66(5):1136-47. PubMed ID: 17961141
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Housefly Phormicin inhibits Staphylococcus aureus and MRSA by disrupting biofilm formation and altering gene expression in vitro and in vivo.
    Wang B; Yao Y; Wei P; Song C; Wan S; Yang S; Zhu GM; Liu HM
    Int J Biol Macromol; 2021 Jan; 167():1424-1434. PubMed ID: 33202277
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Drug-resistance of staphylococcus aureus and detection of mecA gene in all strains isolated from children in Hangzhou].
    Hua CZ; Li JP; Yu HM; Li S; Ye H; Shang SQ
    Zhonghua Er Ke Za Zhi; 2006 May; 44(5):360-3. PubMed ID: 16780714
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy of vancomycin and daptomycin against Staphylococcus aureus isolates collected over 29 years.
    Appleman MD; Citron DM
    Diagn Microbiol Infect Dis; 2010 Apr; 66(4):441-4. PubMed ID: 20226335
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In vitro activities of antibiotics and antimicrobial cationic peptides alone and in combination against methicillin-resistant Staphylococcus aureus biofilms.
    Mataraci E; Dosler S
    Antimicrob Agents Chemother; 2012 Dec; 56(12):6366-71. PubMed ID: 23070152
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evolution of a vancomycin-intermediate Staphylococcus aureus strain in vivo: multiple changes in the antibiotic resistance phenotypes of a single lineage of methicillin-resistant S. aureus under the impact of antibiotics administered for chemotherapy.
    Sieradzki K; Leski T; Dick J; Borio L; Tomasz A
    J Clin Microbiol; 2003 Apr; 41(4):1687-93. PubMed ID: 12682161
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In vivo exposure of insect AMP resistant Staphylococcus aureus to an insect immune system.
    El Shazely B; Urbański A; Johnston PR; Rolff J
    Insect Biochem Mol Biol; 2019 Jul; 110():60-68. PubMed ID: 31051236
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Staphylococcus aureus at an Indian tertiary hospital: Antimicrobial susceptibility and minimum inhibitory concentration (MIC) creep of antimicrobial agents.
    Khurana S; Mathur P; Malhotra R
    J Glob Antimicrob Resist; 2019 Jun; 17():98-102. PubMed ID: 30389637
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Rising incidence of Staphylococcus aureus with reduced susceptibility to vancomycin and susceptibility to antibiotics: a global analysis 2004-2009.
    Hawser SP; Bouchillon SK; Hoban DJ; Dowzicky M; Babinchak T
    Int J Antimicrob Agents; 2011 Mar; 37(3):219-24. PubMed ID: 21239146
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of teicoplanin and vancomycin in vitro activity on clinical isolates of Staphylococcus aureus.
    Tascini C; Flammini S; Leonildi A; Ciullo I; Tagliaferri E; Menichetti F
    J Chemother; 2012 Aug; 24(4):187-90. PubMed ID: 23040680
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Development of novel ultrashort antimicrobial peptide nanoparticles with potent antimicrobial and antibiofilm activities against multidrug-resistant bacteria.
    Almaaytah A; Mohammed GK; Abualhaijaa A; Al-Balas Q
    Drug Des Devel Ther; 2017; 11():3159-3170. PubMed ID: 29138537
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Determination of antimicrobial susceptibility patterns in Staphylococcus aureus strains recovered from patients at two main health facilities in Kabul, Afghanistan.
    Naimi HM; Rasekh H; Noori AZ; Bahaduri MA
    BMC Infect Dis; 2017 Nov; 17(1):737. PubMed ID: 29187146
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In vitro activity of ceftobiprole against meticillin-resistant Staphylococcus aureus (MRSA), vancomycin-intermediate S. aureus (VISA), vancomycin-resistant S. aureus (VRSA) and daptomycin-non-susceptible S. aureus (DNSSA).
    Saravolatz LD; Pawlak J; Johnson LB; Saravolatz LD; Husain N
    Int J Antimicrob Agents; 2010 Nov; 36(5):478-80. PubMed ID: 20846830
    [No Abstract]   [Full Text] [Related]  

  • 55. In vitro evaluation of antibiotics' combinations for empirical therapy of suspected methicillin resistant Staphylococcus aureus severe respiratory infections.
    Drago L; De Vecchi E; Nicola L; Gismondo MR
    BMC Infect Dis; 2007 Sep; 7():111. PubMed ID: 17888153
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antimicrobial synergy of monolaurin lipid nanocapsules with adsorbed antimicrobial peptides against Staphylococcus aureus biofilms in vitro is absent in vivo.
    Rozenbaum RT; Su L; Umerska A; Eveillard M; Håkansson J; Mahlapuu M; Huang F; Liu J; Zhang Z; Shi L; van der Mei HC; Busscher HJ; Sharma PK
    J Control Release; 2019 Jan; 293():73-83. PubMed ID: 30465823
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evolution of multidrug resistance during Staphylococcus aureus infection involves mutation of the essential two component regulator WalKR.
    Howden BP; McEvoy CR; Allen DL; Chua K; Gao W; Harrison PF; Bell J; Coombs G; Bennett-Wood V; Porter JL; Robins-Browne R; Davies JK; Seemann T; Stinear TP
    PLoS Pathog; 2011 Nov; 7(11):e1002359. PubMed ID: 22102812
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bacterial resistance to antimicrobial peptides.
    Abdi M; Mirkalantari S; Amirmozafari N
    J Pept Sci; 2019 Nov; 25(11):e3210. PubMed ID: 31637796
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Bicarbonate induces high-level resistance to the human antimicrobial peptide LL-37 in Staphylococcus aureus small colony variants.
    Zhang P; Wright JA; Tymon A; Nair SP
    J Antimicrob Chemother; 2018 Mar; 73(3):615-619. PubMed ID: 29211886
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacodynamic comparison of different antimicrobial regimens against Staphylococcus aureus bloodstream infections with elevated vancomycin minimum inhibitory concentration.
    da Costa TM; Cuba GT; Morgado PGM; Nicolau DP; Nouér SA; Dos Santos KRN; Kiffer CRV
    BMC Infect Dis; 2020 Jan; 20(1):74. PubMed ID: 31973753
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.